Halberd/Athena GTX Research Promises a Much Brighter Future

Halberd/Athena GTX Research Promises a Much Brighter Future pharmiweb.com Halberd Corporation 22nd May 2024 Effective medications for substance abuse and co-morbidities- specifically, effective medications for the various core substances linked to abuse with and without the co-morbidities of TBI and PTSD. LDN+: This novel combination of low dose Naltrexone and Cyclobenzaprine, patented by Halberd, has […]